Osilodrostat Phosphate

Osilodrostat Phosphate

Systematic Name

4-[(5R)-6,7-Dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluorobenzonitrile dihydrogen phosphate

Osilodrostat Phosphate is indicated for the treatment of endogenous hypercortisolemia in adults with Cushing’s syndrome for whom surgery is not an option or has not been curative.

Therapeutic Category

Cortisol Synthesis Inhibitor

CAS No

104-31-41315449-72-9

Suitable Formulations

Solid

Approvals

Under Development

Do You Have A Question? Lets Have A Talk

Sthree chemicals is a pure-play API manufacturer with a diverse portfolio of capabilities in delivering efficiencies to generic players globally. Founded in 2012 by a team with vast experience across the pharmaceutical value chain, the company is on a mission to become the most preferred partner for pharmaceuticals.